High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
FOX 29 Philadelphia on MSN2d
CHOP doctors named 'Disruptors of the Year' for groundbreaking sickle cell gene therapy
The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...
Medscape11d
Sickle Cell Trait Widely Misinterpreted As Cause of Death
A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.
Harvard Medical School3d
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know
Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...
WCIV Charleston on MSN4d
Gene therapy among cutting-edge treatments at MUSC's new sickle cell center in Charleston
The Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...
Sickle cell gene therapies are gaining steam
Nearly a year after new sickle cell gene therapies were approved, CNBC's Bertha Coombs reports a small number of patients are starting to complete the months-long course of treatments, but the ...
'Groundbreaking' sickle cell treatment to be offered to NHS patients for first time
It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...
New Sickle Cell Center coming to MUSC
Scott Turner Department of Housing and Urban Development secretary, announced a new Department of Government Efficiency Task ...
emjreviews.com2d
Sickle Cell Trait Not Linked to Exertion-Related Death, Study Finds
A SYSTEMATIC review by the American Society of Hematology (ASH) has found no evidence to support sickle cell trait (SCT) as a cause of acute pain crises or sudden exertion-related death. This finding ...
St. Louis American9d
Wash U student study explores sickle cell impact on thinking
In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine ...